Form 8-K - Current report:
SEC Accession No. 0001193125-25-018471
Filing Date
2025-01-31
Accepted
2025-01-31 17:10:12
Documents
15
Period of Report
2025-01-31
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933339d8k.htm   iXBRL 8-K 28883
2 EX-3.1 d933339dex31.htm EX-3.1 28829
3 EX-99.1 d933339dex991.htm EX-99.1 6079
  Complete submission text file 0001193125-25-018471.txt   203647

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bbnx-20250131.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbnx-20250131_lab.xml EX-101.LAB 18723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbnx-20250131_pre.xml EX-101.PRE 11722
17 EXTRACTED XBRL INSTANCE DOCUMENT d933339d8k_htm.xml XML 3822
Mailing Address 11 HUGHES IRVINE CA 92618
Business Address 11 HUGHES IRVINE CA 92618 949-427-7785
Beta Bionics, Inc. (Filer) CIK: 0001674632 (see all company filings)

EIN.: 475386878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42491 | Film No.: 25579379
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)